WFNMB2022/JSNM2022/JSNMT2022

Presentation information

[JSNM]Radiopharmaceuticals3: Therapy2

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演

Radiopharmaceuticals3

Therapy2

Sat. Sep 10, 2022 11:00 AM - 12:00 PM Room6 (Kyoto International Conference Center 2F RoomB-2)

Chair:Izumi Umeda (Kavli Ipmu, Tokyo University), Yasuhiro Magata (Hamamatsu University School Of Medicine)

[M2VIB5] Radiolabeling and evaluation of TRT drug "211At-AITM" derivative

Masayuki Hanyu1、Lin Xie1、Yiding Zhang1、Katsuyuki Minegishi1、Ayumi Kadoma1,2、Kuan Hu1、Masayuki Fujinaga1、Koutaro Nagatsu1、Noriko Ishioka3、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan、2.ATOX CO., LTD., Shiba Front Bldg., 4-11-3 Shiba, Minato-ku, Tokyo 108-0014, Japan、3.Department of Radiation-Applied Biology Reserch, Takasaki Advanced Radiation Research Institute, National Institutes for Quantum Science and Technology, Takasaki, Japan)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password